135 related articles for article (PubMed ID: 36681122)
1. Implications of STAT signalling pathways and its associated molecules in the treatment of Oral Squamous Cell Carcinoma (OSCC).
Anees FF; Sekar D
J Stomatol Oral Maxillofac Surg; 2023 Jun; 124(3):101392. PubMed ID: 36681122
[No Abstract] [Full Text] [Related]
2. Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).
Sekar D
Oral Oncol; 2022 Mar; 126():105763. PubMed ID: 35144207
[No Abstract] [Full Text] [Related]
3. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
4. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.
Petruzzi MN; Cherubini K; Salum FG; de Figueiredo MA
Diagn Pathol; 2017 Apr; 12(1):32. PubMed ID: 28381274
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC).
Sekar D; Selvakumar SC; Auxzilia Preethi K
Oral Oncol; 2022 Nov; 134():106106. PubMed ID: 36067592
[No Abstract] [Full Text] [Related]
6. Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
Yang X; Zhou T; Ji T; Jia H; Liu W
Oral Oncol; 2022 Jul; 130():105901. PubMed ID: 35533509
[No Abstract] [Full Text] [Related]
7. Authors reply to the comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
Sekar D
Oral Oncol; 2023 Feb; 137():106306. PubMed ID: 36623474
[No Abstract] [Full Text] [Related]
8. Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma.
Pandey A; Bhuvanadas S; Joseph JP; Jayaraj R; Devi A
Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2159-2168. PubMed ID: 33882814
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis in oral squamous cell carcinoma: a review.
Singh S; Singh AK
Microbes Infect; 2022; 24(3):104925. PubMed ID: 34883247
[TBL] [Abstract][Full Text] [Related]
10. Methuosis - A promising lead for the treatment of oral squamous cell carcinoma.
Krishnan RP; Ramani P; Pandiar D
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1S):101333. PubMed ID: 36402427
[No Abstract] [Full Text] [Related]
11. The implications of nanodiagnostics and artificial intelligence for detecting oral potentially malignant disorders and oral squamous cell carcinoma.
Liu W; Wang Y; Yang X; Shen X; Shi L
Int J Surg; 2023 Oct; 109(10):3248-3250. PubMed ID: 37352524
[No Abstract] [Full Text] [Related]
12. MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis.
Min A; Zhu C; Peng S; Rajthala S; Costea DE; Sapkota D
Biomed Res Int; 2015; 2015():186904. PubMed ID: 26504785
[TBL] [Abstract][Full Text] [Related]
13. Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
Jayaseelan VP; A S SG; Arumugam P
Oral Oncol; 2022 Jul; 130():105874. PubMed ID: 35533508
[No Abstract] [Full Text] [Related]
14. Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
Sivaperumal P; Sekaran S; Kamala K; Ganapathy D
Oral Oncol; 2022 Aug; 131():105971. PubMed ID: 35716647
[No Abstract] [Full Text] [Related]
15. Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
Zhang S; Han X; Wang M; Shen X
Oral Oncol; 2023 Feb; 137():106298. PubMed ID: 36584496
[No Abstract] [Full Text] [Related]
16. Sonic Hedgehog Signalling Activation Contributes to ALCAM Over-Expression and Poor Clinical Outcome in Patients with Oral Squamous Cell Carcinoma.
Chen G; Yan M; Li RR; Chen WT
Chin J Dent Res; 2018; 21(1):31-40. PubMed ID: 29507910
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. Early Discovery, Early Recovery: The principle behind successful oral squamous cell carcinoma treatment!
Misra SR; Das R
Oral Oncol; 2023 Oct; 145():106511. PubMed ID: 37478573
[No Abstract] [Full Text] [Related]
19. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophages as novel tumor targeting therapy for oral squamous cell carcinoma (OSCC) cancer.
Sivaperumal P; Kamala K
Oral Oncol; 2022 Oct; 133():106020. PubMed ID: 35853322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
